These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Recognising and preventing Duchenne muscular dystrophy. Gardner-Medwin D Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1083-4. PubMed ID: 6414575 [No Abstract] [Full Text] [Related]
43. Human growth hormone and estrogens in boys with Duchenne muscular dystrophy. Chyatte SB; Rudman D; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS Arch Phys Med Rehabil; 1973 Jun; 54(6):248-53. PubMed ID: 4708006 [No Abstract] [Full Text] [Related]
44. [X-ray CT of Duchenne muscular dystrophy skeletal muscles--chronological study for five years]. Shimizu J; Matsumura K; Kawai M; Kunimoto M; Nakano I Rinsho Shinkeigaku; 1991 Sep; 31(9):953-9. PubMed ID: 1769158 [TBL] [Abstract][Full Text] [Related]
45. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy]. Ceccarelli A; Leone P Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497 [No Abstract] [Full Text] [Related]
46. Duchenne muscular dystrophy: comparison among different racial groups. Bortolini ER; Zatz M Am J Med Genet; 1987 Dec; 28(4):925-9. PubMed ID: 3688030 [TBL] [Abstract][Full Text] [Related]
47. [Genetics and clinical types of progressive muscular dystrophy; creatine kinase and myoglobin as biochemical indices of the disease]. Miyoshi K; Kawai H; Sasaki H; Iwaasa M; Yagita M; Ise H; Kondo A; Hiasa M Nihon Rinsho; 1977 Nov; 35(11):3891-6. PubMed ID: 599669 [No Abstract] [Full Text] [Related]
49. The detection of female carriers of pseudohypertrophic muscular dystrophy. Kakulas BA; Knight JO; Gubbay SS; Mastaglia FL Proc Aust Assoc Neurol; 1968; 5(3):545-51. PubMed ID: 5709982 [No Abstract] [Full Text] [Related]
50. Studies on the creatine kinase MM isoforms of normal and Duchenne muscular dystrophic patients. Zhao X; Bi C; Yang Z Chin Med J (Engl); 1998 Jan; 111(1):75-7. PubMed ID: 10322660 [TBL] [Abstract][Full Text] [Related]
51. Carbonic anhydrase III in Duchenne muscular dystrophy. Carter ND; Heath R; Jeffery S; Jackson MJ; Newham DJ; Edwards RH Clin Chim Acta; 1983 Sep; 133(2):201-8. PubMed ID: 6414742 [TBL] [Abstract][Full Text] [Related]
52. [Mental development in Duchenne muscular dystrophy. Correlation of data of the brain scanner]. Septien L; Gras P; Borsotti JP; Giroud M; Nivelon JL; Dumas R Pediatrie; 1991; 46(12):817-9. PubMed ID: 1667037 [TBL] [Abstract][Full Text] [Related]
56. CT of primary muscle diseases. Jiddane M; Gastaut JL; Pellissier JF; Pouget J; Serratrice G; Salamon G AJNR Am J Neuroradiol; 1983; 4(3):773-6. PubMed ID: 6410854 [TBL] [Abstract][Full Text] [Related]
57. Studies on muscular dystrophy. A comparison of the steady kinetics of the normal human ATP-creatine transphosphorylase isoenzymes (creatine kinases) with those from tissues of Duchenne muscular dystrophy. Jacobs HK; Kuby SA J Biol Chem; 1980 Sep; 255(18):8477-82. PubMed ID: 7410371 [No Abstract] [Full Text] [Related]